Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) Revenue (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Revenue for 3 consecutive years, with $43.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue fell 18.33% year-over-year to $43.4 million, compared with a TTM value of $178.5 million through Sep 2025, up 10.54%, and an annual FY2024 reading of $205.4 million, up 6.13% over the prior year.
  • Revenue was $43.4 million for Q3 2025 at SBC Medical Group Holdings, roughly flat from $43.4 million in the prior quarter.
  • Across five years, Revenue topped out at $54.8 million in Q1 2024 and bottomed at $448127.0 in Q4 2023.
  • Average Revenue over 3 years is $43.0 million, with a median of $47.3 million recorded in 2023.
  • The sharpest move saw Revenue skyrocketed 9812.49% in 2024, then decreased 18.35% in 2025.
  • Year by year, Revenue stood at $448127.0 in 2023, then surged by 9812.49% to $44.4 million in 2024, then fell by 2.4% to $43.4 million in 2025.
  • Business Quant data shows Revenue for SBC at $43.4 million in Q3 2025, $43.4 million in Q2 2025, and $47.3 million in Q1 2025.